TBPHNasdaq Cayman Islands
Market cap
$872.792 M
$16.93 +0.06%
Close of 7 Aug 2026
Revenue
$107.5M
#2492 by revenue
Earnings
$105.9M
#1291 by earnings
Shares outstanding
51,553,005
Latest filing cover page
P/E ratio
8.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Theravance Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.